Reply to Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
نویسندگان
چکیده
Correspondence to Dr Giovanni Merola; [email protected] Laparoscopic surgery for the treatment of right colon cancer has rapidly evolved over the past few years. This procedure is considered as feasible and effective in terms of short-term and long-term outcomes. Laparoscopic right colectomy (LRC) is performed by a small number of surgeons and, in most of cases, it was performed with an extracorporeal anastomosis. The recent ESMO guidelines with a Level of Evidence (LE) IV reported that for right-sided colonic cancers, the benefits of laparoscopic approach are less obvious since anastomosis must be hand sewn, which requires a laparotomy. The current state of the art for the treatment of the right colon cancers as reported by Fabozzi et al.3 in their papers, by right laparoscopic colectomy with intracorporeal anastomosis despite the technical challenging. However, in the past few years, many studies comparing the intracorporeal anastomosis (IA) versus the extracorporeal anastomosis (EA) in LRC were conducted 4–8 with a higher level of evidence. These papers assessed short-term and long-term outcomes of LRC. Milone et al in their multicentric, comparative and prospective study (LE III) evaluated the safety of IA versus EA in 512 patients submitted to an LCR. They concluded that the IA represents the better way to perform the anastomosis after LRC. van Oostendorp et al in their meta-analysis of about 24 non-randomised studies comparing IA versus EA reported morbidity, mortality and length of stay; moreover, they also investigated the rates of anastomotic leak rate, ileus, incisional surgical site infection (SSI) and incisional hernia, concluding that IA in LRC is associated with reduced shortterm morbidity and decreased length of hospital stay suggesting faster recovery. Hanna et al in their retrospective multicentre study of about 195 patients evaluated both long and short terms outcomes, with a follow-up of 5.7 years, concluding that IA in LRC is associated with similar postoperative and oncologic outcomes compared to EA. Furthermore, IA may overcomes the EA about many advantages in terms of flexibility of specimen extraction, even if it burdened by a higher rate of minor complications (Grade II of Dindo classification). In another prospective study (LE III) published by Shapiro et al, a total of 191 consecutive patients who underwent LRC for neoplasm with IA and EA were evaluated. The mean follow up for the two group of patients was 33.7 months for EA group and 28.8 months for IA one. They evaluated both short and long terms outcomes. They concluded that LRC with IA were associated with improved shortand long-term outcomes. The rates of postoperative complications requiring intervention and incisional hernias were decreased. Abrisqueta et al in their retrospective study of 173 patients concluded that the IA represent a safe and feasible alternative for creating an ileo-colic anastomosis. It involves a similar rate of complications and may prevent some of the drawbacks presented by EA. The most relevant data highlighted by previous studies 4–7 is the reduction of the operating time and reduction of incisional hernias in the groups treated with IA anastomosis ensuring in any case adequate oncological outcomes. These data are consistent with the conclusions of a recent meta-analysis. Out of a total of 1717 patients, the authors confirmed that LCR with IA is a safe alternative to EA. However, each of the previous studies does not provide for the highest level of evidence but in any case provides that LCR can be effectively performed through an IA. More generally, there is a broad consensus in the surgical current practice that a
منابع مشابه
Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up F. Cardoso, L. Fallowfield, A. Costa, M. Castiglione & E. Senkus On behalf of the ESMO Guidelines Working Group* European School of Oncology, Milan, Italy; Breast Cancer Unit, Champalimaud Cancer Center, Lisbon, Portugal; Brighton & Sussex Medical School, University of Sussex,...
متن کاملGastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up A. Okines, M. Verheij, W. Allum, D. Cunningham & A. Cervantes On behalf of the ESMO Guidelines Working Group* GI Clinical Trials Unit, Royal Marsden Hospital, Sutton, UK; Department of Radiation Oncology and Division of Cellular Biochemistry, The Netherlands Cancer Institute—Antoni van Leeuwenhoek Hospital,...
متن کاملRectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up B. Glimelius, L. Påhlman & A. Cervantes On behalf of the ESMO Guidelines Working Group* Department of Oncology, Radiology and Clinical Immunology; Department of Surgical Science, Akademiska Sjukhuset, University of Uppsala, Uppsala, Sweden; Department of Hematology and Medical Oncology, INCLIVA, University o...
متن کاملNon-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up N. Reed, D. Millan, R. Verheijen & M. Castiglione On behalf of the ESMO Guidelines Working Group* Beatson Oncology Centre, Glasgow; Department of Pathology, Glasgow Royal Infirmary, UK; Department of Gynecological Oncology, University Medical Center, Utrecht, The Netherlands; RGT, University ...
متن کاملCancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up G. Pentheroudakis, R. Orecchia, H. J. Hoekstra & N. Pavlidis On behalf of the ESMO Guidelines Working Group* Department of Medical Oncology, Ioannina University Hospital, Ioannina, Greece; Department of Radiation Oncology, European Institute of Oncology and University of Milan, Milan, Italy...
متن کاملPancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up S. Cascinu, M. Falconi, V. Valentini & S. Jelic On behalf of the ESMO Guidelines Working Group* Department of Medical Oncology, Università Politecnica delle Marche, Ancona; Department of Surgery and Gastroenterology, University of Verona, Verona; Department of Radiotherapy, Università Cattolica del Sacro...
متن کامل